Fuan Pharmaceutical Group Co Cash Flow Conversion Efficiency

Latest as of September 2025: 0.023x

Fuan Pharmaceutical Group Co cash flow conversion efficiency. Based on the latest financial reports, Fuan Pharmaceutical Group Co (300194) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥100.27 Million ≈ $14.67 Million USD) by net assets (CN¥4.45 Billion ≈ $651.79 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Fuan Pharmaceutical Group Co (2007–2025)

Cash flow conversion efficiency of Fuan Pharmaceutical Group Co from 2007 to 2025. This chart illustrates how Fuan Pharmaceutical Group Co's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Fuan Pharmaceutical Group Co for real-time trading data and today's change.

Fuan Pharmaceutical Group Co Cash Flow Conversion Ratio Explained

Fuan Pharmaceutical Group Co cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Fuan Pharmaceutical Group Co Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Fuan Pharmaceutical Group Co ranked by their cash flow conversion efficiency. Also see 300194 market cap for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Qfin Holdings, Inc.
NASDAQ:QFIN
0.044x
Ningxia Xinri Hengli Steel Wire Rope Co Ltd
SHG:600165
-0.040x
Weikeng Industrial Co Ltd
TW:3033
-0.355x
Zhejiang Zomax Transmission
SHG:603767
0.010x
Zhejiang Chunhui Intelligent Control Co. Ltd.
SHE:300943
-0.001x
Beijing Asiacom Information Technology Co.Ltd
SHE:301085
N/A
Zee Entertainment Enterprises Limited
NSE:ZEEL
-0.002x
Jenkem Technology Co Ltd
SHG:688356
-0.013x

Annual Cash Flow Conversion Efficiency for Fuan Pharmaceutical Group Co (2007–2025)

The table below shows the annual cash flow conversion efficiency of Fuan Pharmaceutical Group Co from 2007 to 2025. Review Fuan Pharmaceutical Group Co free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥4.37 Billion
≈ $638.81 Million
CN¥312.32 Million
≈ $45.70 Million
0.072x +3.65%
2024-12-31 CN¥4.40 Billion
≈ $643.58 Million
CN¥303.59 Million
≈ $44.42 Million
0.069x -12.95%
2023-12-31 CN¥4.15 Billion
≈ $607.09 Million
CN¥328.98 Million
≈ $48.14 Million
0.079x -7.82%
2022-12-31 CN¥3.95 Billion
≈ $577.49 Million
CN¥339.50 Million
≈ $49.68 Million
0.086x +29.34%
2021-12-31 CN¥3.87 Billion
≈ $565.70 Million
CN¥257.13 Million
≈ $37.63 Million
0.067x +86.38%
2020-12-31 CN¥4.56 Billion
≈ $666.55 Million
CN¥162.55 Million
≈ $23.79 Million
0.036x -51.84%
2019-12-31 CN¥3.99 Billion
≈ $583.77 Million
CN¥295.63 Million
≈ $43.26 Million
0.074x +2.27%
2018-12-31 CN¥3.69 Billion
≈ $540.55 Million
CN¥267.68 Million
≈ $39.17 Million
0.072x -33.34%
2017-12-31 CN¥4.17 Billion
≈ $610.29 Million
CN¥453.37 Million
≈ $66.34 Million
0.109x +15.16%
2016-12-31 CN¥3.96 Billion
≈ $580.00 Million
CN¥374.16 Million
≈ $54.75 Million
0.094x +25.23%
2015-12-31 CN¥2.14 Billion
≈ $312.59 Million
CN¥161.03 Million
≈ $23.56 Million
0.075x +511.64%
2014-12-31 CN¥1.71 Billion
≈ $249.86 Million
CN¥-31.27 Million
≈ $-4.58 Million
-0.018x -135.25%
2013-12-31 CN¥1.72 Billion
≈ $252.41 Million
CN¥89.61 Million
≈ $13.11 Million
0.052x +42.41%
2012-12-31 CN¥1.72 Billion
≈ $251.77 Million
CN¥62.77 Million
≈ $9.18 Million
0.036x -4.80%
2011-12-31 CN¥1.69 Billion
≈ $247.66 Million
CN¥64.85 Million
≈ $9.49 Million
0.038x -89.82%
2010-12-31 CN¥281.05 Million
≈ $41.13 Million
CN¥105.74 Million
≈ $15.47 Million
0.376x -2.08%
2009-12-31 CN¥163.31 Million
≈ $23.90 Million
CN¥62.75 Million
≈ $9.18 Million
0.384x -13.55%
2008-12-31 CN¥110.76 Million
≈ $16.21 Million
CN¥49.23 Million
≈ $7.20 Million
0.444x -80.47%
2007-12-31 CN¥8.31 Million
≈ $1.22 Million
CN¥18.92 Million
≈ $2.77 Million
2.276x --

About Fuan Pharmaceutical Group Co

SHE:300194 China Drug Manufacturers - Specialty & Generic
Market Cap
$640.66 Million
CN¥4.38 Billion CNY
Market Cap Rank
#10644 Global
#2825 in China
Share Price
CN¥3.68
Change (1 day)
+2.22%
52-Week Range
CN¥3.34 - CN¥4.76
All Time High
CN¥10.53
About

Fuan Pharmaceutical (Group) Co., Ltd., together with its subsidiaries, research and develops, produces, and sells chemical drugs in the People's Republic of China and internationally. It offers APIs; intermediates; and FDFs, such as anti-tumor, specialty drugs, antibiotics, as well as freeze-drying preparation for injection. The company was formerly known as Chongqing Fuan Pharmaceutical (Group) … Read more